BAPOTULIMAB
UNII I92BM16NTD

Substance Identification & Data

This profile provides standardized clinical and technical data for Bapotulimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I92BM16NTD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2359413-58-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
I92BM16NTD
CAS Registry Number
2359413-58-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BAPOTULIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11503
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bapotulimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BAPOTULIMAB

Common Names & Synonyms

BAPOTULIMAB [INN]
BAPOTULIMAB [WHO-DD]
IMMUNOGLOBULIN G2 (DE-446-LYSINE), ANTI-(HUMAN IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2) (HUMAN MONOCLONAL BAY 1905254 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BAY 1905254 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS ILDR2 (IMMUNOGLOBULIN LIKE DOMAIN CONTAINING RECEPTOR 2, C1ORF32)), HOMO SAPIENSMONOCLONAL ANTIBODY (BAPOTULIMAB)

Technical Codes

BAY-1905254